Phase III BEACON Trial Results Promising for Patients With Metastatic Colorectal Cancer
Updated phase III results from the BEACON study have found that encorafenib with cetuximab can lead to promising survival outcomes among patients with advanced colorectal cancer (CRC) who had received previous lines of treatment. The third most common cancer and the third most common cause of cancer-related deaths in the U.S., CRC occurs when there […]